Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia
Europe & Central Asia: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and was 11.2% in 2021. ▼ Falling
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia, 2000–2021
Source: World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Measured in %.
Analysis
The most recent figure for mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia is 11.2%, measured in 2021.
That represents a change of up 2.3% on the previous year and down 15.0% over ten years.
Over the whole period, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia peaked at 16.6% in 2000 and was at its lowest, 10.9%, in 2020.
Europe & Central Asia ranks 41st of 47 groups on this measure, in the bottom quarter.
The long-run direction has been consistently falling across the 22 years of available data.
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 16.6% | — |
| 2001 | 16.3% | -1.8% |
| 2002 | 16.2% | -0.6% |
| 2003 | 16.1% | -1.1% |
| 2004 | 15.6% | -2.9% |
| 2005 | 15.5% | -0.5% |
| 2006 | 14.9% | -4.0% |
| 2007 | 14.4% | -3.1% |
| 2008 | 14.2% | -1.5% |
| 2009 | 13.8% | -2.7% |
| 2010 | 13.6% | -1.8% |
| 2011 | 13.1% | -3.2% |
| 2012 | 12.8% | -2.7% |
| 2013 | 12.5% | -2.6% |
| 2014 | 12.5% | +0.5% |
| 2015 | 12.2% | -2.9% |
| 2016 | 12.0% | -1.0% |
| 2017 | 11.8% | -2.3% |
| 2018 | 11.7% | -0.5% |
| 2019 | 11.3% | -3.1% |
| 2020 | 10.9% | -3.7% |
| 2021 | 11.2% | +2.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 15.4% | 13.8% | 16.6% | 10 |
| 2010s | 12.4% | 11.3% | 13.6% | 10 |
| 2020s | 11.0% | 10.9% | 11.2% | 2 |
Countries ranked near Europe & Central Asia
- 38 Mozambique 22.3% compare
- 39 Namibia 22.1% compare
- 40 Niger 21.6% compare
- 40 Zambia 21.6% compare
- 42 Egypt 21.4% compare
- 42 Turkmenistan 21.4% compare
- 44 Burkina Faso 21.3% compare
- 44 Cote d'Ivoire 21.3% compare
- 44 Morocco 21.3% compare
- 44 Senegal 21.3% compare
More health data for Europe & Central Asia
- Population ages 45-49, female, annual growth rate 0.9265 % change on previous year (2025)
- Population ages 45-49, male, per capita 0.0339 units per person (2025)
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0299 units per person (2025)
- Population ages 45-49, male, annual growth rate 1.04 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0346 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, male, annual growth rate 0.6344 % change on previous year (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, per capita 0.0352 units per person (2025)
Frequently asked questions
- What is mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia?
- Mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia was 11.2% in 2021, according to World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO).
- What is the highest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Europe & Central Asia?
- The highest recorded value was 16.6% in 2000.
- What is the lowest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Europe & Central Asia?
- The lowest recorded value was 10.9% in 2020.
- How does Europe & Central Asia rank for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Europe & Central Asia ranks 41st out of 47 groups with data for 2021.
- Is mortality from cvd, cancer, diabetes or crd between exact ages 30 and rising or falling in Europe & Central Asia?
- Over the last ten years it is down 15.0%. The long-run trend across the full record is falling.
- Where does this Europe & Central Asia data come from?
- The figures come from World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as part of Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).